Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus

Thrombosis Research, 10/01/2010

Diabetic patients with coronary artery disease had significantly higher levels of both platelet aggregation and activation compared to non–diabetic patients with coronary artery disease despite treatment with the same dosage of aspirin. These findings may partly explain the reduced cardiovascular protection from aspirin in diabetic patients.

Print Article Summary

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List